Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
EDQM
0
USP
0
JP
0
Others
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 5-(8-amino-7-chloro-2,3-dihydro-1,4-benzodioxin-5-yl)-3-(1-(2-phenylethyl)-4-piperidinyl)-1,3,4-oxadiazol-2(3h)-one
2. Sl 65.0155
3. Sl-65.0155
4. Sl65.0155
1. 769901-96-4
2. Capeserod [inn]
3. Sl65.0155
4. 5-(8-amino-7-chloro-2,3-dihydrobenzo[b][1,4]dioxin-5-yl)-3-(1-phenethylpiperidin-4-yl)-1,3,4-oxadiazol-2(3h)-one
5. Unii-8163770l8p
6. 8163770l8p
7. 5-(5-amino-6-chloro-2,3-dihydro-1,4-benzodioxin-8-yl)-3-[1-(2-phenylethyl)piperidin-4-yl]-1,3,4-oxadiazol-2-one
8. 5-(8-amino-7-chloro-2,3-dihydro-1,4-benzodioxin-5-yl)-3-[1-(2-phenylethyl)piperidin-4-yl]-1,3,4-oxadiazol-2(3h)-one
9. Sl650155
10. 5-(8-amino-7-chloro-2,3-dihydro-1,4-benzodioxin-5-yl)-3-(1-(2-phenylethyl)piperidin-4-yl)-1,3,4-oxadiazol-2(3h)-one
11. D09zqx
12. Gtpl29
13. Schembl4707724
14. Chembl2027925
15. Bdbm86038
16. Dtxsid60998277
17. Pdsp1_001263
18. Pdsp2_001247
19. Ft-0735661
20. A923297
21. Q27075681
22. 5-(8-amino-7-chloro-2,3-dihydro-1,4-benzodioxin-5-yl)-3-[1-(2-phenylethyl)piperidin-4-yl]-2,3-dihydro-1,3,4-oxadiazol-2-one
| Molecular Weight | 456.9 g/mol |
|---|---|
| Molecular Formula | C23H25ClN4O4 |
| XLogP3 | 3.8 |
| Hydrogen Bond Donor Count | 1 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 5 |
| Exact Mass | g/mol |
| Monoisotopic Mass | g/mol |
| Topological Polar Surface Area | 89.6 |
| Heavy Atom Count | 32 |
| Formal Charge | 0 |
| Complexity | 696 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
83
PharmaCompass offers a list of Capeserod API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Capeserod manufacturer or Capeserod supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Capeserod manufacturer or Capeserod supplier.
PharmaCompass also assists you with knowing the Capeserod API Price utilized in the formulation of products. Capeserod API Price is not always fixed or binding as the Capeserod Price is obtained through a variety of data sources. The Capeserod Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.
A Capeserod manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Capeserod, including repackagers and relabelers. The FDA regulates Capeserod manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Capeserod API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Capeserod supplier is an individual or a company that provides Capeserod active pharmaceutical ingredient (API) or Capeserod finished formulations upon request. The Capeserod suppliers may include Capeserod API manufacturers, exporters, distributors and traders.
Capeserod Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Capeserod GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Capeserod GMP manufacturer or Capeserod GMP API supplier for your needs.
A Capeserod CoA (Certificate of Analysis) is a formal document that attests to Capeserod's compliance with Capeserod specifications and serves as a tool for batch-level quality control.
Capeserod CoA mostly includes findings from lab analyses of a specific batch. For each Capeserod CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Capeserod may be tested according to a variety of international standards, such as European Pharmacopoeia (Capeserod EP), Capeserod JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Capeserod USP).
